{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:53:15Z","timestamp":1793904795820,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103644"],"award-info":[{"award-number":["P20GM103644"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ypmed.2023.107625","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T20:26:44Z","timestamp":1689625604000},"page":"107625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["The fourth wave of the overdose crisis: Examining the prominent role of psychomotor stimulants with and without fentanyl"],"prefix":"10.1016","volume":"176","author":[{"given":"Richard A.","family":"Rawson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler G.","family":"Erath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Westley","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ypmed.2023.107625_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-020-00211-9","article-title":"Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial","volume":"16","author":"Becker","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"issue":"5","key":"10.1016\/j.ypmed.2023.107625_bb0005","doi-asserted-by":"crossref","first-page":"e218049","DOI":"10.1001\/jamanetworkopen.2021.8049","article-title":"Comparison of treatments for cocaine use disorder among adults: a systematic review and meta-analysis","volume":"4","author":"Bentzley","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.ypmed.2023.107625_bb0010","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/add.15242","article-title":"Pharmacotherapeutic strategies for treating cocaine use disorder\u2014what do we have to offer?","volume":"116","author":"Brandt","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.ypmed.2023.107625_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108307","article-title":"Contingency management for the treatment of methamphetamine use disorder: a systematic review","volume":"216","author":"Brown","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.ypmed.2023.107625_bb0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/YCO.0000000000000518","article-title":"Medications to treat cocaine use disorders: current options","volume":"32","author":"Buchholz","year":"2019","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.ypmed.2023.107625_bb0025","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.ypmed.2023.107625_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108193","article-title":"A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders","volume":"216","author":"Chan","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ypmed.2023.107625_bb0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int J Drug Pol"},{"issue":"4","key":"10.1016\/j.ypmed.2023.107625_bb0040","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"10.1016\/j.ypmed.2023.107625_bb0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jamapsychiatry.2019.3655","article-title":"Effects of mirtazapine for methamphetamine use disorder among cisgender men and transgender women who have sex with men: a placebo-controlled randomized clinical trial","volume":"77","author":"Coffin","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.ypmed.2023.107625_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002715","article-title":"Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: a systematic review and network meta-analysis","volume":"15","author":"De Crescenzo","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.ypmed.2023.107625_bb0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.drugalcdep.2017.12.020","article-title":"The national implementation of contingency management (CM) in the Department of Veterans Affairs: attendance at CM sessions and substance use outcomes","volume":"185","author":"DePhilippis","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ypmed.2023.107625_bb0060","article-title":"Charting the fourth wave: geographic, temporal, race\/ethnicity, and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010\u20132021","author":"Friedman","year":"2022","journal-title":"medRxiv"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107625_bb0065","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1176\/appi.ajp.2021.21040381","article-title":"Surging racial disparities in the US overdose crisis","volume":"179","author":"Friedman","year":"2022","journal-title":"Am J Psychiatr"},{"issue":"1","key":"10.1016\/j.ypmed.2023.107625_bb0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1037\/ccp0000552","article-title":"Long-term efficacy of contingency management treatment based on objective indicators of abstinence from illicit substance use up to 1 year following treatment: a meta-analysis","volume":"89","author":"Ginley","year":"2021","journal-title":"J Consult Clin Psychol"},{"issue":"5","key":"10.1016\/j.ypmed.2023.107625_bb0075","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jamapsychiatry.2020.4321","article-title":"Methamphetamine overdose deaths in the US by sex and race and ethnicity","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ypmed.2023.107625_bb0080","article-title":"Increase in drug overdose deaths involving cocaine: United States, 2009\u20132018","volume":"384","author":"Hedegaard","year":"2020","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ypmed.2023.107625_bb0085","series-title":"Drug overdose deaths in the United States, 1999\u20132020","first-page":"1","volume":"356","author":"Hedegaard","year":"2021"},{"key":"10.1016\/j.ypmed.2023.107625_bb0090","first-page":"763","article-title":"Achieving cocaine abstinence with a behavioral approach","author":"Higgins","year":"1993","journal-title":"Am J Psychiatry.150(5)"},{"issue":"7","key":"10.1016\/j.ypmed.2023.107625_bb0095","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/archpsyc.1994.03950070060011","article-title":"Incentives improve outcome in outpatient behavioral treatment of cocaine dependence","volume":"51","author":"Higgins","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ypmed.2023.107625_bb0100","series-title":"Contingency Management in Substance Abuse Treatment","author":"Higgins","year":"2007"},{"issue":"4","key":"10.1016\/j.ypmed.2023.107625_bb0105","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2105\/AJPH.2022.307212","article-title":"Methamphetamine-related mortality in the United States: co-involvement of heroin and fentanyl, 1999-2021","volume":"113","author":"Hoopsick","year":"2023","journal-title":"Am J Public Health"},{"issue":"9","key":"10.1016\/j.ypmed.2023.107625_bb0110","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/jama.2023.1041","article-title":"Implementing the white House\u2019s strategic plan to save lives amid the opioid crisis: reaching for the \u201cnorth star\u201d","volume":"329","author":"Incze","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2023.107625_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106541","article-title":"The fourth wave of the US opioid epidemic and its implications for the rural US: a federal perspective","volume":"152","author":"Jenkins","year":"2021","journal-title":"Prev Med"},{"issue":"8","key":"10.1016\/j.ypmed.2023.107625_bb0120","doi-asserted-by":"crossref","first-page":"e2226544","DOI":"10.1001\/jamanetworkopen.2022.26544","article-title":"Association of methamphetamine and opioid use with nonfatal overdose in rural communities","volume":"5","author":"Korthuis","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ypmed.2023.107625_bb0125","author":"Office of National Drug Control Policy"},{"issue":"5","key":"10.1016\/j.ypmed.2023.107625_bb0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1192\/pb.bp.110.031831","article-title":"Contingency management: what it is and why psychiatrists should want to use it","volume":"35","author":"Petry","year":"2011","journal-title":"Psychiatrist"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107625_bb0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1037\/0022-006X.68.2.250","article-title":"Give them prizes and they will come: contingency management for treatment of alcohol dependence","volume":"68","author":"Petry","year":"2000","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"10.1016\/j.ypmed.2023.107625_bb0140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1521-0391.2014.12092.x","article-title":"Nationwide dissemination of contingency management: the veterans administration initiative","volume":"23","author":"Petry","year":"2014","journal-title":"Am J Addict"},{"issue":"11","key":"10.1016\/j.ypmed.2023.107625_bb0145","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","article-title":"Contingency management for treatment of substance use disorders: a meta- analysis","volume":"101","author":"Prendergast","year":"2006","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107625_bb0150","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/JAC.0000000000000450","article-title":"Contingency Management for Stimulant use Disorder: Progress, challenges, and recommendations","volume":"46","author":"Rawson","year":"2023","journal-title":"J Ambulat Care Manag"},{"issue":"9","key":"10.1016\/j.ypmed.2023.107625_bb0155","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.addbeh.2013.03.018","article-title":"Duration effects in contingency management treatment of methamphetamine disorders","volume":"38","author":"Roll","year":"2013","journal-title":"Addict Behav"},{"key":"10.1016\/j.ypmed.2023.107625_bb0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.clinpsy.2.022305.095219","article-title":"Contingency management for treatment of substance abuse","volume":"2","author":"Stitzer","year":"2006","journal-title":"Annu Rev Clin Psychol"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107625_bb0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa2020214","article-title":"Bupropion and naltrexone in methamphetamine use disorder","volume":"384","author":"Trivedi","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ypmed.2023.107625_bib166","series-title":"Contingency Management for Substance Use Disorders","author":"Washington State Policy Institute","year":"2021"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743523002050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743523002050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:19:37Z","timestamp":1758795577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743523002050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":35,"alternative-id":["S0091743523002050"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2023.107625","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The fourth wave of the overdose crisis: Examining the prominent role of psychomotor stimulants with and without fentanyl","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2023.107625","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107625"}}